Veratrum Viride Root

Summary

Veratrum Viride Root (CHEMBL1201531) is an approved unknown (ATC C02KA01); indicated across 1 condition including hypertensive disorder.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Unknown
• ATC class: C02KA01
• Indications: 1 condition

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1201531
Name	Veratrum Viride Root
Type	Unknown
Max phase	4
ATC	C02KA01

Also known as: American hellebore, American hellebore root, American hellebore whole, American white hellebore root, American white hellebore whole, Green false hellebore root, Green false hellebore whole, Green veratrum, Indian poke root, Indian poke whole, Veratrum, Veratrum alkaloids

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

1 indication (1 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
hypertensive disorder	4	MONDO:0005044	EFO:0000537

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).